Loading...

Cancer Treatments & Financial Returns

38 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Jun 11, 2019

A much-publicized report by the World Health Organization advocates that the price of cancer treatments are excessive. However, its analysis contains significant biases that drastically over-estimates the revenues multiple over research and development (R&D) costs, according to a new issue brief from the Center for Medical Economics and Innovation at the non-partisan Pacific Research Institute. Download a copy of the brief at www.medecon.org.

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...